Skip to main content
J Frontier Co.,Ltd. logo

J Frontier Co.,Ltd. — Investor Relations & Filings

Ticker · 2934 ISIN · JP3386650000 LEI · 353800HXWRYUK3D9E382 T Human health and social work activities
Open in API
Filings indexed 56 across all filing types
Latest filing 2024-02-21 Annual Report
Country JP Japan
Listing T 2934

About J Frontier Co.,Ltd.

https://jfrontier.jp/

J Frontier Co., Ltd. is a healthcare technology company primarily engaged in the e-commerce of pharmaceuticals and health-related products. The company operates through several key business areas: healthcare sales, which includes the planning, manufacturing, and sale of its own health foods and beauty products; medical sales, focusing on an online medication guidance and prescription drug mail-order platform; and healthcare marketing, which provides digital marketing and promotional support to other companies. By leveraging digital technology, J Frontier aims to drive the digital transformation of the medical and pharmaceutical sectors, making healthcare services more accessible and contributing to the overall health and well-being of society.

Recent filings

Filing Released Lang Actions
訂正有価証券報告書－第15期(2022/06/01－2023/05/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of an Annual Report (10-K). It contains comprehensive financial data, including consolidated financial statements, management indicators, and business information for the fiscal year ending May 31, 2023. It is not an announcement or a certification, but the full report itself. FY 2023
2024-02-21 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is extremely short (596 characters) and contains a confirmation statement regarding the appropriateness of a quarterly report ('四半期報告書') for the second quarter of the 16th fiscal period (September 1, 2023, to November 30, 2023). The header indicates it is a '確認書' (Confirmation Document) submitted to the Kanto Local Finance Bureau Director, citing Article 24-4-8, Paragraph 1 of the Financial Instruments and Exchange Act. This structure strongly suggests a certification or confirmation related to financial reporting, often accompanying a formal filing. Since it is a confirmation *about* a quarterly report, and not the full quarterly report itself, and given its brevity, it is most likely a regulatory filing or a specific confirmation document. The closest fit among the provided codes for a document confirming the accuracy of a periodic report, which is not the report itself, is often categorized under general regulatory filings or specific confirmation documents. However, since the content explicitly deals with the accuracy confirmation of a 'Quarterly Report' (which corresponds to an Interim Report, code IR), and this confirmation document itself is a specific regulatory submission, it fits best as a general Regulatory Filing (RNS) or potentially a specific type of Audit/Review document if it were a formal sign-off. Given the context of confirming a quarterly report's accuracy under Japanese law, and the document being a short confirmation rather than the full report (IR), RNS is the most appropriate fallback for a specific regulatory confirmation document that doesn't match the main report types.
2024-01-12 Japanese
四半期報告書－第16期第2四半期(2023/09/01－2023/11/30)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, including the balance sheet, for the second quarter of the 16th fiscal period (June 1, 2023, to November 30, 2023). As it is a comprehensive quarterly financial report containing actual financial data and analysis, it falls under the 'Interim / Quarterly Report' category. H1 2024
2024-01-12 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act in Japan. It specifically confirms the accuracy of the contents of a Quarterly Report (四半期報告書) for the first quarter of the 16th fiscal period. Since this is a regulatory filing confirming the accuracy of a report rather than the report itself, and it does not fit into the specific categories like 10-K or IR, it falls under the general regulatory filing category.
2023-10-13 Japanese
四半期報告書－第16期第1四半期(2023/06/01－2023/08/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, as indicated by the header and the regulatory reference (Financial Instruments and Exchange Act). It contains comprehensive financial statements, including the balance sheet and management analysis for the first quarter of the 16th fiscal period (June 1, 2023, to August 31, 2023). It is not an announcement of a report, but the report itself, containing substantive financial data. Q1 2024
2023-10-13 Japanese
臨時報告書
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a 'Rinji Hokokusho' (Extraordinary Report) filed with the Kanto Local Finance Bureau. It explicitly details the results of a general meeting of shareholders, including the number of votes for, against, and abstentions for specific agenda items (such as articles of incorporation changes and director appointments). This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2023-08-30 Japanese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.